These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10686057)

  • 1. European multi-centre validation study of NucliSens Extractor in combination with HCV Amplicor 2.0 assay for HCV-NAT screening of plasma pools.
    Cuypers HT; van Dijk R; Viret JF; Schottstedt V; Lankinen M; Da Silva Cardoso M; Lelie PN
    Biologicals; 1999 Dec; 27(4):303-14. PubMed ID: 10686057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screening.
    Cuijpers HT; Molijn MH; Bos HJ; Peeters AP; van der Poel CL; Lelie PN
    Vox Sang; 2001 Jul; 81(1):12-20. PubMed ID: 11520410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of HCV RNA and HIV RNA blood screening assays.
    Lelie PN; van Drimmelen HA; Cuypers HT; Best SJ; Stramer SL; Hyland C; Allain JP; Moncharmont P; Defer C; Nübling M; Glauser A; da Silva Cardoso M; Viret JF; Lankinen MH; Grillner L; Wirthmüller U; Coste J; Schottstedt V; Masecar B; Dax EM
    Transfusion; 2002 May; 42(5):527-36. PubMed ID: 12084160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
    Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
    Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.
    Palomäki P; Wessberg S; Tuomi K; Laitinen H
    Transfusion; 2005 Sep; 45(9):1518-22. PubMed ID: 16131386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
    Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
    Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
    Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
    Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of automated nucleic acid extraction devices for application in HCV NAT.
    Jongerius JM; Bovenhorst M; van der Poel CL; van Hilten JA; Kroes AC; van der Does JA; van Leeuwen EF; Schuurman R
    Transfusion; 2000 Jul; 40(7):871-4. PubMed ID: 10924618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems.
    Beld M; Habibuw MR; Rebers SP; Boom R; Reesink HW
    Transfusion; 2000 May; 40(5):575-9. PubMed ID: 10827262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance characteristics of the AmpliScreen HIV-1 test, an assay designed for screening plasma mini-pools.
    Yang Y; Wisbeski MH; Mendoza M; Dorf S; Xu D; Nguyen M; Yeh S; Sun R
    Biologicals; 1999 Dec; 27(4):315-23. PubMed ID: 10686058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of HCV-NAT assays and experience with NAT application for blood screening in Germany.
    Nübling CM; Chudy M; Löwer J
    Biologicals; 1999 Dec; 27(4):291-4. PubMed ID: 10686055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy.
    Mancini C; Pisani G; Azzi A; Luisa Zerbini M; Gentili G; Mario Bisso G;
    J Clin Virol; 2004 Aug; 30(4):313-9. PubMed ID: 15163420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
    Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
    Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World Health Organization collaborative study to calibrate the 3rd International Standard for Hepatitis C virus RNA nucleic acid amplification technology (NAT)-based assays.
    Baylis SA; Heath AB;
    Vox Sang; 2011 May; 100(4):409-17. PubMed ID: 21488880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.
    Konnick EQ; Williams SM; Ashwood ER; Hillyard DR
    J Clin Microbiol; 2005 May; 43(5):2133-40. PubMed ID: 15872232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; David B; De Micco P
    Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of validation studies from a fractionator's point of view.
    Zerlauth G
    Biologicals; 1999 Dec; 27(4):295-301. PubMed ID: 10686056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.